Acute Pain Clinical Trial
Official title:
Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting: A Prospective Cluster-randomized Comparison of 2 vs. 3 μg/kg/Transport
| Verified date | October 2017 |
| Source | University of Aarhus |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
In a previous study the investigators evaluated the apparent efficacy and safety of
intravenous fentanyl administered by ambulance personnel and found that 58.4% (CI 56.4-60.4)
out of 2348 prehospital patients treated with fentanyl still experienced moderate to severe
pain [numeric rating scale (NRS, 0-10) > 3] at hospital arrival. The number of patients with
possible fentanyl-related side effects was low.
Therefore, the aim of the present study is to explore the efficacy and safety of a
liberalized pain treatment protocol for ambulance personnel (a total of 3 μg/kg per
transport) compared with existing restrictive protocol (a total of 2 μg/kg per transport).
The investigators hypothesize that:
- A higher proportion of patients will experience sufficient pain relief at hospital
admission (NRS < 4) using the liberalized protocol and
- There will be no differences in the proportion of potential fentanyl related
side-effects are observed.
| Status | Completed |
| Enrollment | 7093 |
| Est. completion date | October 2017 |
| Est. primary completion date | October 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A to 110 Years |
| Eligibility |
Inclusion Criteria: - Patients with acute pain treated with intravenous fentanyl by ambulance personnel Exclusion Criteria: - Reduced conscious level (GCS < 15) before initiation of fentanyl treatment - Reduced respiratory rate (< 10/minute) before initiation of fentanyl treatment - Patient weight < 30 kg - Known opioid allergy - Women in labour - Chronic pain conditions |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Aarhus | Central Denmark Region |
Friesgaard KD, Nikolajsen L, Giebner M, Rasmussen CH, Riddervold IS, Kirkegaard H, Christensen EF. Efficacy and safety of intravenous fentanyl administered by ambulance personnel. Acta Anaesthesiol Scand. 2016 Apr;60(4):537-43. doi: 10.1111/aas.12662. Epub 2015 Nov 27. — View Citation
Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482. — View Citation
Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014 Aug;29(8):541-9. doi: 10.1007/s10654-014-9930-3. Epub 2014 Jun 26. Review. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Proportion of patients with sufficient pain relief (NRS < 4) at hospital arrival | Up to 6 hours | ||
| Secondary | Proportion of patients with reduced Glasgow Coma Scale (<15) after fentanyl administration and at any given point during transport | Up to 6 hours | ||
| Secondary | Proportion of patients with reduced respiratory rate (<10/minute) after fentanyl administration and at any given point during transport | Up to 6 hours | ||
| Secondary | Proportion of patients with reduced peripheral oxygen saturation (< 90%) after fentanyl administration and at any given point during transport | Up to 6 hours | ||
| Secondary | Proportion of patients with hypotension after fentanyl administration and at any given point during transport | Hypotension defined as a drop in mean arterial pressure (MAP) >= 10 mmHg to a MAP < 70 mmHg | Up to 6 hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
| Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
| Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
| Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
| Completed |
NCT03825549 -
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
|
N/A | |
| Completed |
NCT05995912 -
Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain
|
Phase 2 | |
| Recruiting |
NCT05589246 -
Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure
|
N/A | |
| Recruiting |
NCT05572190 -
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
|
Phase 1 | |
| Terminated |
NCT04716413 -
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
|
Phase 4 | |
| Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
| Not yet recruiting |
NCT06317844 -
Examination of Psychological and Physiological Pathways Linking Gratitude and Pain
|
N/A | |
| Withdrawn |
NCT02957097 -
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
|
Phase 4 | |
| Completed |
NCT02565342 -
Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery
|
Phase 4 | |
| Terminated |
NCT02599870 -
Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures
|
N/A | |
| Completed |
NCT02380989 -
Integrative Ayurveda Healing Relieves Minor Sports Injury Pain
|
Phase 2 | |
| Completed |
NCT02984098 -
40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose
|
Phase 4 | |
| Completed |
NCT02489630 -
Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department
|
Phase 4 | |
| Completed |
NCT03107338 -
Preventive Treatment of Pain After Dental Implant Surgery
|
Phase 4 | |
| Completed |
NCT02817477 -
Intranasal Ketamine for Acute Traumatic Pain
|
Phase 4 |